COVID-19 Management offers clinically proven antiviral solutions to support patients through every stage of the disease. With a focus on evolving challenges of viral infections, Hetero formulated innovative drugs like Covifor (Remdesivir), Favivir (Favipiravir), Movfor (Molnupiravir) and Barcy (Baricitinib) that help reduce disease severity and support patient recovery. Backed by scientific research, quality manufacturing, and a commitment to accessible healthcare, Hetero Healthcare continues to provide trusted solutions helping healthcare professionals in delivering effective COVID-19 management.
View by-
